Magnitude of Multidrug Resistance and Associated Factors of Pulmonary Tuberculosis Among Adult Smear Positive Patients in Eastern Ethiopia

References

• World Health Organization. Multidrug and extensively drug-resistant TB (M/XDR): 2010 global report on surveillance and response. Geneva; 2010.
   Google Scholar
• World Health Organization. World Health Organization, report. Global tuberculosis report 2017. Geneva, Switzerland: World Health Organization; 2017.
   Google Scholar
• Mak A, Thomas A, DelGranado M, Zaleskis R, Mouzafarova N, Menzies D. Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. Am J Respir Crit Care Med. 2008;178(3):306–312. doi:10.1164/rccm.200802-240OC18511706
   PubMed Web of Science ®Google Scholar
• World Health Organization. World Health Organization, report. Global tuberculosis report 2019. Geneva, Switzerland: World Health Organization; 2019.
   Google Scholar
• World Health Organization. World Health Organization, report. Global tuberculosis report 2018. Geneva, Switzerland: World Health Organization; 2018.
   Google Scholar
• Muller B, Streicher E, Chihota V, Pillay M, Klopper M, Coetzee G. Programmatically selected multidrug-res istant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa. PLoS One. 2013;8(8):e70919. doi:10.1371/journal.pone.007091924058399
   PubMed Web of Science ®Google Scholar
• World Health Organization. World Health Organization, global tubelosis report. Geneva, Switzerland: Worled Health Organization; 2014. Available from: www.who.int/about/licensing/copyright_form/en/index.html. Accessed October 2, 2021.
   Google Scholar
• World Health Organization. World Health Organization, Report. Global tuberculosis report 2013. Geneva, Switzerland: World Health Organization; 2013.
   Google Scholar
• Kebede AH, Alebachew Z, Tsegaye F, Fmo H; Federal Minstry of Health. The first population-based national tuberculosis prevalence survey in Ethiopia, 2010–2011. Int J Tuberc Lung Dis. 2014;18(16):635–639. doi:10.5588/ijtld.13.041724903931
   PubMed Web of Science ®Google Scholar
• Mitike G, Kebede D, Yeneneh H. Prevalence of antituberculosis drug resistance in Harar Tuberculosis Centre, Ethiopia. East Afr Med J. 1997;74(3):158–161.9185412
   PubMed Web of Science ®Google Scholar
• CSA. Population census of Ethiopia. Central Statistic Authority; 2007.
   Google Scholar
• Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance patterns of Mycobacterium tuberculosis complex and associated factors among retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015;15:599. doi:10.1186/s12889-015-1955-326135909
   PubMed Web of Science ®Google Scholar
• Ahmad AM, Akhtar S, Hasan R, Khan JA. Risk factors for multidrug-resistant tuberculosis in urban Pakistan: a multicenter case – control study. Int J Mycobacteriol. 2012;1(3):137–142. doi:10.1016/j.ijmyco.2012.07.00726787209
   PubMedGoogle Scholar
• Mekonnen F, Tessema B, Moges F, et al. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis. 2015;15(1):461.26503269
   PubMed Web of Science ®Google Scholar
• Fikadu T. Risk factors for multi-drug resistant tuberculosis in Addis Ababa, Ethiopia. Univ J Public Health. 2015;3(2):1–6.
   Google Scholar
• Desissa F, Workineh T, Beyene T. Risk factors for the occurrence of multidrug-resistant tuberculosis among patients undergoing multidrug-resistant tuberculosis treatment in East Shoa, Ethiopia. BMC Public Health. 2018;18(1):422. doi:10.1186/s12889-018-5371-329606112
   PubMed Web of Science ®Google Scholar
• World Health Organization. Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis; 2010.
   Google Scholar
• World Health Organization. Molecular line probe assay for rapid screening of patients at risk of multidrug resistant tuberculosis (MDR-TB); 2008.
   Google Scholar
• World Healt Organization. Definitions and reporting framework for tuberculosis–2013 revision; 2013.
   Google Scholar
• Brhane M, Kebede A, Petros Y. Molecular detection of multidrug-resistant tuberculosis among smear- positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia. Infect Drug Resist. 2017;10:75–83. doi:10.2147/IDR.S12790328331348
   PubMed Web of Science ®Google Scholar
• Ahmed E, Ibrahim A, Mulualem A, Mengistu E, Muluwork G, Zelalem Y. Drug resistance pattern of mycobacterium tuberculosis in Eastern Amhara Regional State, Ethiopia. Microb Biochem Technol. 2014;6:2.
   Google Scholar
• Nigus DM, Lingerew WM, Beyene BA, et al. Prevalence of multi drug resistant tuberculosis among presumptive multi drug resistant tuberculosis cases in Amhara National Regional State, Ethiopia. J Mycobac Dis. 2014;4:152. doi:10.4172/2161-1068.1000152
   Google Scholar
• Seyoum B, Demissie M, Worku A, Bekele S, Aseffa A. Prevalence and drug resistance patterns of mycobacterium tuberculosis among new smear positive pulmonary tuberculosis patients in Eastern Ethiopia. Hindawi Publ Corporation Tuberculosis Res Treat. 2014;2014:1–7. doi:10.1155/2014/753492
   Google Scholar
• Timirea C, Metcalfe JZ, Chirenda J, et al. Prevalence of drug- resistanttuberculosisinZimbabwe:Ahealthfacility-basedcross-sectionalsurvey. Int J Infect Dis. 2019;87:119–125.31357057
   PubMed Web of Science ®Google Scholar
• Faustini A, Hall J, Peruci C. Risk factors for multi drug tuberculosis in Europe: systematic review. BMJ. 2005;61(2):158–163.
   Google Scholar
• Wondemagegn M, Daniel M, Mulat Y, Aschalew A, Bayeh A. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci. 2015;15:368–377.26124781
   PubMed Web of Science ®Google Scholar
• Flora MS, Amin MN, Karim MR, Afroz S, Islam S, Alam M. Risk factors of multi-drug- resistant tuberculosis in Bangladeshi population: a case control study. Bangladesh Med Res Counc Bull. 2013;39:34–41. doi:10.3329/bmrcb.v39i1.1580823923410
   PubMedGoogle Scholar
• Rahman MA, Hussain MW, Alam F, Jahan MS. Multi-drug resistant tuberculosis: experience in Bogra. J Teachers Assoc. 2005;18(1):3–6.
   Google Scholar
• Oluwaseun E, Akinniyi P, Afolabi O. Primary multi-drug resistant tuberculosis among HIV seropositive and seronegative patients in Abeokuta, Southwestern Nigieria. Am J Res Commun. 2013;1(10):224–237.
   Google Scholar
• Mulisa G, Workneh T, Hordofa N, Suaudi M, Abebe G, Jarso G. Multi- drug resistant Mycobacterium tuberculosis and associated risk factors in the Oromia region of Ethiopia. Int J Infect Dis. 2015;39:57–61. doi:10.1016/j.ijid.2015.08.01326327121
   PubMed Web of Science ®Google Scholar
• Semunigus T, Tessema B, Eshetie S, et al. Smear positive pulmonary tuberculosis and associated factors among homeless individuals in Dessie and Debre Birhan towns, Northeast Ethiopia. Ann Clin Microbiol Antimicrob. 2016;15:50. doi:10.1186/s12941-016-0165-x.27581729
   PubMed Web of Science ®Google Scholar
• Sinha P, Srivastava GN, Gupta A, Anupurba S. Association of risk factors and drug resistance pattern in tuberculosis patients in north India. J Global Infect Dis. 2017;9:139.
   Google Scholar